Tag

Khiron's Zerenia is to provide "Integrative Health Services and Pharmacotherapeutic Treatment with Medical Cannabis" to Capital Salud patients.

The Khiron sponsored study found 9 out of 10 patients reported some degree of improvement of their chronic pain.

The 4,000 square foot facility features 11 patient rooms and according to Khiron, can handle 40,000 patient consultations per year.

Year to date medical cannabis prescriptions have exceeded 35,000 units, 600% more than the entire 2020 fiscal year. Khiron will expand its flagship clinic brand, Zerenia to the UK, with the first Zerenia opening in London in Q4 2021.

Hired in October 2019 to the role of Managing Director and Chief Legal Counsel, Khiron Europe, Katterbach's promotion to the position of President aligns with the company's commitment to diversity and inclusion throughout the organization, including at the executive level, the...

The UN body allocated 131,000 pounds of dried marijuana flower production to Colombia, 21.84% of the entire world total.

Khiron Life Sciences Corp. ( (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), has announced that its wholly-owned clinic network, the Latin American Institute of Neurology and the Nervous System (“ILANS”), has partnered with Colombian health insurance company...

The Canadian company with its main operations in Colombia sold more than 14.3 million common shares for $0.90 per share to raise the funding.

The Toronto-based company, which has its main operations in Colombia, is trading under the ticker symbol KHRNF.